BioSpace News Archive

Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and nine months ended September 30, 2020.

NeurOptics’ Neurological Pupil index (NPi) and automated pupillometry are now included in the updated 2020 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) as an objective measurement supporting brain injury prognosis in patients following cardiac arrest.

The Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer (SU2C), announced today the launch of a new public service announcement (PSA) campaign, in collaboration with SU2C Ambassador and actress, writer and director Keesha Sharp, to raise awareness for pancreatic cancer research.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has announced William Dauer , MD, director of the Peter O’Donnell Jr. Brain Institute and professor of neurology and neuroscience at the University of Texas Southwestern Medical Center in Dallas , as the recipient of the sixth annual Bachmann-Strauss Prize for Excellence i

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it has appointed Dr. Monica Bertagnolli to its board of directors.

Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, is expanding its research collaboration with parent company Sumitomo Chemical Co., Ltd. by establishing a dedicated Biorational Research Unit at Sumitomo Chemical’s Health & Crop Sciences Research Laboratory (HCRL) in Takarazuka, Hyogo, Japan

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders, is pleased to announce that Rick Pauls, President and CEO of DiaMedica, will participate in a fireside chat and host one-on-one meetings with invest

Covis Group S.à r.l. (“Covis”) today announced that data demonstrating that the investigational anticoagulant reversal agent ciraparantag binds to unfractionated heparin, low molecular weight heparin (LMWH) and direct oral anticoagulants (DOACs) were published in Blood, the journal of the American Society of Hematology (ASH).

Soft Bones, Inc., an organization dedicated to providing information, education and support to those affected by hypophosphatasia (HPP), is pleased to award its annual Maher Family Grant to Flávia Amadeu de Oliveira, PhD, a post-doctoral associate at the Millan Lab at Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, to study the potential of gene therapy in HPP.

Subtle will use the funds to grow their product portfolio and support the global demand to make medical imaging faster and safer for all.